TOMI Environmental Solutions, Inc. Reports Full Year 2025 Financial Results and Outlines Growth Initiatives

Core Insights - TOMI Environmental Solutions, Inc. reported financial results for the year ended December 31, 2025, highlighting strategic initiatives aimed at long-term growth [1] Financial Results - Sales for 2025 were $5,636,000, a decrease from $7,739,000 in 2024, attributed to customers deferring capital expenditures due to economic uncertainties [5] - Gross profit margin remained strong at approximately 55%, indicating operational efficiency [5] - Operating loss was ($3,854,000) for 2025, compared to a loss of ($4,105,000) in 2024 [5] - Net loss for 2025 was $(3,749,000) or $(0.19) per share, an improvement from a net loss of $(4,477,000) or $(0.22) per share in 2024 [5][25] - Cash and cash equivalents as of December 31, 2025, were $88,000, with working capital of $1.0 million [8] Recent Business Highlights - The company strengthened government relationships, notably being selected by NASA for a biosecurity operation [5] - New customer acquisitions included global CDMOs and prestigious university research groups [5] - Regulatory developments in the food market have expanded applications for SteraMist iHP, particularly in food safety [5] - International revenue increased to approximately 29% of total revenue, up from 21% in the previous year [5] Operational Efficiencies - Total operating expenses were reduced by approximately 10% in 2025 [5] - The company is exploring AI-related technologies to enhance operational efficiency [5] Product Innovation - Continued investment in R&D to expand SteraMist® applications across various sectors, resulting in a more comprehensive product portfolio [5] - SteraMist was recognized as the Disinfection and Decontamination Products Company of the Year 2025 by MedTech Outlook [5] Strategic Validation - A USDA study confirmed the efficacy of BIT against deformed wing virus for agricultural biosecurity in honeybees [5] Liquidity and Capital Access - The company completed a $535,000 convertible note financing to support growth initiatives [8] - An equity line of credit allows the company to sell up to $20,000,000 in common stock over a 24-month period [8] Market Opportunities - The food safety market is projected to grow from $28 million in 2025 to $31 million in 2026 [9] - The global medical device sterilization market is valued at $5.29 billion [10] - The company aims to penetrate the biofuel market and enhance domestic energy security [10] Looking Ahead - The company enters 2026 with strong operational momentum and a sales pipeline valued at $16 million for integration projects and $20 million for SteraMist iHP [11] - Focus on clean manufacturing, AI-enabled automation, and biosecurity to drive sustainable long-term growth [11]